The Clinical Efficiency and the Mechanism of Sanzi Yangqin Decoction for Chronic Obstructive Pulmonary Disease

Table 2

Molecular docking of main active compounds of SZYQD and core targets.

Target name	PDB ID	Compound	Energy (kcal/mol)
EGFR	5y9t	Beta-sitosterol	−5.28
EGFR	5y9t	Exceparl M-OL	−5.24
EGFR	5y9t	Luteolin	−7.16
EGFR	5y9t	Phthalic acid, butyl isohexyl ester	−5.19
EGFR	5y9t	Sinoacutine	−5.26
EGFR	5y9t	Stigmasterol	−6.27
MMP9	5th9	Beta-sitosterol	−5.28
MMP9	5th9	Exceparl M-OL	−6.00
MMP9	5th9	Luteolin	−8.4
MMP9	5th9	Phthalic acid, butyl isohexyl ester	−5.84
MMP9	5th9	Sinoacutine	−5.82
MMP9	5th9	Stigmasterol	−6.02
MMP2	3ayu	Beta-sitosterol	−5.12
MMP2	3ayu	Exceparl M-OL	−5.48
MMP2	3ayu	Luteolin	−7.21
MMP2	3ayu	Phthalic acid, butyl isohexyl ester	−6.24
MMP2	3ayu	Sinoacutine	−5.82
MMP2	3ayu	Stigmasterol	−6.25
APP	3ktm	Beta-sitosterol	−5.23
APP	3ktm	Exceparl M-OL	−5.71
APP	3ktm	Luteolin	−7.00
APP	3ktm	Phthalic acid, butyl isohexyl ester	−5.30
APP	3ktm	Sinoacutine	−6.77
APP	3ktm	Stigmasterol	−5.34
ERBB2	3wlw	Beta-sitosterol	−5.87
ERBB2	3wlw	Exceparl M-OL	−5.53
ERBB2	3wlw	Luteolin	−7.10
ERBB2	3wlw	Phthalic acid, butyl isohexyl ester	−5.33
ERBB2	3wlw	Sinoacutine	−5.02
ERBB2	3wlw	Stigmasterol	−5.68
PTGS2	5kir	Beta-sitosterol	−6.12
PTGS2	5kir	Exceparl M-OL	−5.89
PTGS2	5kir	Luteolin	−7.50
PTGS2	5kir	Phthalic acid, butyl isohexyl ester	−5.35
PTGS2	5kir	Sinoacutine	−5.21
PTGS2	5kir	Stigmasterol	−6.82

Note. Docking scores of main active compounds of SZYQD in the disease-compound-target network and the top 6-degree value of the target genes in the PPI network. The lower the energy of binding with receptors is, the greater the possibility of action is.